| 1.52 0.26 (20.63%) | 08-04 15:59 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.92 |
1-year : | 2.25 |
| Resists | First : | 1.64 |
Second : | 1.92 |
| Pivot price | 1.17 |
|||
| Supports | First : | 1.26 |
Second : | 1.02 |
| MAs | MA(5) : | 1.22 |
MA(20) : | 1.21 |
| MA(100) : | 1.26 |
MA(250) : | 1.28 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 75.7 |
D(3) : | 48.9 |
| RSI | RSI(14): 59.9 |
|||
| 52-week | High : | 4.92 | Low : | 0.3 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ QUCY ] has closed Bollinger Bands are 62.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 19 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.53 - 1.54 | 1.54 - 1.54 |
| Low: | 1.24 - 1.24 | 1.24 - 1.25 |
| Close: | 1.51 - 1.52 | 1.52 - 1.53 |
Quantum Cyber N.V. operates as a technology company focused on cybersecurity and quantum computing solutions. The company pursues acquisitions and partnerships in areas including post-quantum cryptography, zero-trust architecture, and national security technologies. It also develops platforms that integrate artificial intelligence (AI) and quantum computing technologies for autonomous control systems used in unmanned aerial, ground, and underwater vehicles, including drones, self-driving vehicles, and robotic fleets. Quantum Cyber N.V. was formerly known as Mainz Biomed N.V. and changed its name to Quantum Cyber N.V. in April 2026. The company is headquartered in Mainz, Germany.
Mon, 27 Jul 2026
Mainz Biomed N V Ord Shs (QUCY) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Sat, 25 Jul 2026
QUCY|Mainz Biomed N V Ord Shs|Price:1.140|Chg%:+0.030 - TradingKey
Tue, 28 Apr 2026
David E. Lazar Secures CEO Role at Mainz Biomed N.V. with 97.4% Stake - tradingview.com
Tue, 31 Mar 2026
Mainz Biomed 10-K: Revenue $0.537M, EPS $(2.70) - tradingview.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Diagnostics & Research
|
|
| Shares Out | 0 (M) |
| Shares Float | 23 (M) |
| Held by Insiders | 1.348e+007 (%) |
| Held by Institutions | 6.9 (%) |
| Shares Short | 1,920 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -1.27e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -2 % |
| Return on Assets (ttm) | 460.7 % |
| Return on Equity (ttm) | -94.3 % |
| Qtrly Rev. Growth | 537080 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | -131.41 |
| EBITDA (p.s.) | 170214 |
| Qtrly Earnings Growth | -2.1 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -10 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.02 |
| Price to Cash Flow | 9.66 |
| Dividend | 0 |
| Forward Dividend | 2.81e+006 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|